Skip to main content

Table 2 Treatment results

From: Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma

Patient

Clinical stage

Post-treatment MRI TRG

Post-treatment endoscopy response

Time to surgery (weeks)

Pathologic stage

Radial Margin

Pathologic TRG

NAR

1

T2 N1

3

No post-treatment endoscopy

18.1

T3 N1

Negative

Not assessed

41.6

2

T2 N1

–

Complete

–

–

–

–

N/A

3

T2 N2

3

No post-treatment endoscopy

12.9

T2 N0

Negative

1

15

4

T2 N2

1

Complete

–

–

–

–

N/A

5

T2 N2

3

Not complete

25.7

TisN0

Negative

0*

0

6

T3 N0

2

No post-treatment endoscopy

17.3

T0 N0

Negative

0

0.9

7

T3 N0

2

Complete

–

–

–

–

N/A

8

T3 N1

–

No post-treatment endoscopy

12.3

T0 N0

Negative

0

0.9

9

T3 N1

2

Not complete

13.0

T3 N0

Negative

1

15

10

T3 N1

2

Complete

16.9

T3 N1

Negative

1

30.1

11

T3 N1

2

Not complete

13.6

T0 N0

Negative

0

0.9

12

T3 N2

2

Not complete

23.4

T3 N2

Positive

3

50.4

13

T3 N2

3

Not complete

17.9

T1 N0

Negative

2

3.7

14

T3 N2

3

Not complete

17.3

T1 N0

Negative

3

3.7

15

T3 N2

1

Not complete

13.6

T0 N0

Negative

0

0.9

16

T3 N2

3

No post-treatment endoscopy

14.1

T2 N1

Negative

2

20.4

17

T3 N2

1

Complete

–

–

–

–

N/A

18

T3 N2

2

No post-treatment endoscopy

13.9

T0 N0

Negative

0

0.9

19

T3 N2

2

Complete

24.3

T0 N0

Negative

0

0.9

20

T3 N2

3

Complete

18

T3 N1

Negative

2

30.1

21

T3 N2

3

Not complete

13.6

T3 N1

Negative

2

20.4

22

T4bN0

1

Complete

–

–

–

–

N/A

23

T4aN1

–

No post-treatment endoscopy

13

T0 N0

Negative

0

0

24

T4aN2

3

Not complete

13.9

T3 N1

Positive

2

20.4

25

T4aN2

3

Not complete

13.1

T3 N1

Negative

2

20.4

26

T4bN2

3

Complete

–

–

–

–

N/A

  1. Abbreviations: TRG treatment response grade, CCR clinical complete response, NAR neoadjuvant response score
  2. Note: Patients without pathology assessment were those followed with watch-and-wait approach. Pathologic tumor regression of 0 represents pathologic complete response. *The patient with pTis disease is assigned a score of 0